Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech

Country: European Union

Language: Latvian

Source: EMA (European Medicines Agency)

Active ingredient:

cilvēka IgG1 monoklonāla antiviela, kas raksturīga cilvēka interleukīna-1 alfa

Available from:

XBiotech Germany GmbH

ATC code:

L01

INN (International Name):

human IgG1 monoclonal antibody specific for human interleukin-1 alpha

Therapeutic group:

Antineoplastiski līdzekļi

Therapeutic area:

Kolorektālie jaunveidojumi

Therapeutic indications:

Ārstēšana ar metastātisku kolorektālu vēzi.

Authorization status:

Atteikts

Documents in other languages

Public Assessment Report Public Assessment Report Bulgarian 15-09-2017
Public Assessment Report Public Assessment Report Spanish 15-09-2017
Public Assessment Report Public Assessment Report Czech 15-09-2017
Public Assessment Report Public Assessment Report Danish 15-09-2017
Public Assessment Report Public Assessment Report German 15-09-2017
Public Assessment Report Public Assessment Report Estonian 15-09-2017
Public Assessment Report Public Assessment Report Greek 15-09-2017
Public Assessment Report Public Assessment Report English 15-09-2017
Public Assessment Report Public Assessment Report French 15-09-2017
Public Assessment Report Public Assessment Report Italian 15-09-2017
Public Assessment Report Public Assessment Report Lithuanian 15-09-2017
Public Assessment Report Public Assessment Report Hungarian 15-09-2017
Public Assessment Report Public Assessment Report Maltese 15-09-2017
Public Assessment Report Public Assessment Report Dutch 15-09-2017
Public Assessment Report Public Assessment Report Polish 15-09-2017
Public Assessment Report Public Assessment Report Portuguese 15-09-2017
Public Assessment Report Public Assessment Report Romanian 15-09-2017
Public Assessment Report Public Assessment Report Slovak 15-09-2017
Public Assessment Report Public Assessment Report Slovenian 15-09-2017
Public Assessment Report Public Assessment Report Finnish 15-09-2017
Public Assessment Report Public Assessment Report Swedish 15-09-2017
Public Assessment Report Public Assessment Report Croatian 15-09-2017